Page last updated: 2024-08-17

quinoxalines and Fanconi Anemia

quinoxalines has been researched along with Fanconi Anemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alsina, M; Beg, AA; Boulware, D; Chen, DT; Dalton, WS; Hazlehurst, LA; Mathews, L; Oliveira, V; Shain, KH; Villagra, A; Wang, X; Yarde, DN	1

Other Studies

1 other study(ies) available for quinoxalines and Fanconi Anemia

Article	Year
Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma. Cancer research, 2009, Dec-15, Volume: 69, Issue:24 Topics: Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; Gene Expression; Humans; Imidazoles; Melphalan; Multiple Myeloma; NF-kappa B; Pyrazines; Quinoxalines; Transcription Factor RelB	2009

Article

Year

Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma.

Cancer research, 2009, Dec-15, Volume: 69, Issue:24

Topics: Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; Gene Expression; Humans; Imidazoles; Melphalan; Multiple Myeloma; NF-kappa B; Pyrazines; Quinoxalines; Transcription Factor RelB

2009